Opinion leaders are:
a. formal leaders who lead evidence-based practice development teams.
b. formal leaders who write new evi-dence-based practice guidelines.
c. informal leaders who influence peers by evaluating innovations for use in certain settings and promoting clinicians' use of evidence in clinical decision making.
d. informal leaders who gather data about nursing practice changes.
C
Informal leaders who influence peers by evaluating innovations for use in certain settings and promoting clinicians' use of evidence in clinical decision making are referred to as opinion lead-ers. Opinion leaders are likeable, trustworthy, informative, and influential (Doumit et al., 2007; Majumdar et al., 2007).
You might also like to view...
A nurse is preparing to teach a forgetful older adult patient about a multiple drug regimen to follow after discharge from the hospital. To help promote adherence, what will the nurse do?
a. Ask the patient to share the teaching with a neighbor or friend soon after discharge. b. Give the patient detailed written informa-tion about each drug. c. Cluster medication administration times as much as possible. d. Make sure the patient understands the ac-tions and side effects of each drug.
The hospital has a well-designed, fully functioning ethics committee. What ethical debate topics, concerning the entire social network rather than an individual patient, might now be addressed by this committee?
1. Autonomy 2. Informed consent 3. Duplication of services 4. Do-not-resuscitate orders
One function of cholecystokinin is to:
a. transport bile to gallbladder b. stimulate contraction of the gallbladder wall c. synthesize albumin d. produce bilirubin
A child with non-Hodgkin's lymphoma will be starting chemotherapy. Which intervention is initiated before chemotherapy to prevent tumor lysis syndrome?
a. Insertion of a central venous catheter b. Intravenous (IV) hydration containing sodium bicarbonate c. Placement of an externalized ventriculoperitoneal (VP) shunt d. Administration of pneumococcal and H. influenzae type B vaccines